29
Quality Control of Radiopharmaceuticals Lab # 5

Quality Control of Radiopharmaceuticals

  • Upload
    cayla

  • View
    212

  • Download
    17

Embed Size (px)

DESCRIPTION

Quality Control of Radiopharmaceuticals. Lab # 5. Quality Control of Radiopharmaceuticals. Radiopharmaceuticals they undergo strict quality control measures Involves several specific tests and measurements that ensure Purity Potency Product identity Biologic safety Efficacy. - PowerPoint PPT Presentation

Citation preview

Page 1: Quality Control of Radiopharmaceuticals

Quality Control ofRadiopharmaceuticals

Lab # 5

Page 2: Quality Control of Radiopharmaceuticals

Quality Control ofRadiopharmaceuticals

• Radiopharmaceuticals they undergo strict quality control measures

• Involves several specific tests and measurements that ensure – Purity– Potency– Product identity– Biologic safety– Efficacy

Page 3: Quality Control of Radiopharmaceuticals

Physicochemical Tests

• Tests that are essential for the determination of the purity and integrity of a radiopharmaceutical.

• Some of these tests are unique for radiopharmaceuticals because they contain radionuclides.

Page 4: Quality Control of Radiopharmaceuticals

Physical Characteristics

• One should be familiar with the color and state of a radiopharmaceutical

• A true solution should not contain any particulate matter

• Any deviation from the original color and clarity should be viewed with concern because it may reflect changes in the radiopharmaceutical that would alter its biologic behavior

Page 5: Quality Control of Radiopharmaceuticals

• Colloidal or aggregate preparations should have a proper size range of particles for a given purpose

Page 6: Quality Control of Radiopharmaceuticals

pH and Ionic Strength• All radiopharmaceuticals should have

an appropriate hydrogen ion concentration or pH for their stability and integrity

• Ideal pH of a radiopharmaceutical should be 7.4

• pH can vary between 2 and 9 because of the high buffer capacity of the blood

Page 7: Quality Control of Radiopharmaceuticals

pH and Ionic Strength• Measured by a pH meter

• Radiopharmaceuticals must also have proper – Ionic strength– Isotonicity– Osmolality in order to be suitable for human administration

• How to achieve Correct ionic strength?• By adding a proper

– Acid– Alkali– Electrolyte

Page 8: Quality Control of Radiopharmaceuticals

Radionuclidic Purity

• Defined as– The fraction of the total radioactivity in the

form of the desired radionuclide present in a radiopharmaceutical

• Impurities arise from– Extraneous nuclear reactions due to isotopic

impurities in the target material– Fission of heavy elements in the reactor

Page 9: Quality Control of Radiopharmaceuticals

Radionuclidic Purity

• The undesirable radionuclides may belong to the same element as the desired radionuclide or to a different element

• Impurities can be removed by appropriate chemical methods

• Radionuclidic purity is determined by measuring the half-lives and characteristic radiations emitted by individual radionuclides

Page 10: Quality Control of Radiopharmaceuticals

Radiochemical Purity

• Defined as• The fraction of the total radioactivity in the

desired chemical form in the radiopharmaceutical

• Radiochemical impurities arise from • Decomposition due to the action of solvent• Change in temperature or pH, light• Presence of oxidizing or reducing agents

Page 11: Quality Control of Radiopharmaceuticals

Radiochemical Purity

• The presence of radiochemical impurities in a radiopharmaceutical results in poor-quality images due to the high background from the surrounding tissues and the blood, and gives unnecessary radiation dose to the patient

Page 12: Quality Control of Radiopharmaceuticals

Radiochemical Purity

• Decomposition of labeled compounds by radiolysis depends on– The specific activity of the radioactive material– The type and energy of the emitted radiation– The half-life of the radionuclide

Page 13: Quality Control of Radiopharmaceuticals

Radiochemical Purity

• Absorption of radiations by labeled molecules results in the formation of free radicals with unpaired electrons

• Which in turn leads to further decomposition of other molecules.

• A secondary process due to radiolysis produces H2O2 or HO2 : from decomposition of water

(solvent)• Which reacts with and ultimately decomposes

labeled molecules.

Page 14: Quality Control of Radiopharmaceuticals

Radiochemical Purity• The stability of a compound is time-dependent

on exposure to light, change in temperature, and radiolysis

• The longer a compound is exposed to these conditions, the more it will tend to break down

• How to lessen the degradation of the material?

• Substances such as sodium ascorbate, ascorbic acid, and sodium sulfite are often added to maintain the stability of radiopharmaceuticals

• Some radiopharmaceuticals are stored in the dark under refrigeration

Page 15: Quality Control of Radiopharmaceuticals

Radiochemical Purity• Analytical methods used to detect and determine the

radiochemical impurities in a given radiopharmaceutical:– Precipitation– Paper and Instant Thin-Layer Chromatography– Gel Chromatography– Paper or Polyacrylamide Gel Electrophoresis– Ion Exchange– Solvent Extraction– High-Performance Liquid Chromatography– Distillation

Page 16: Quality Control of Radiopharmaceuticals

Chemical Purity

• The fraction of the material in the desired chemical form whether or not all of it is in the labeled form

• Aluminum is a chemical impurity in the 99mTc-eluate

• The presence of a slight amount of globulins in the preparation of albumin is indicative of impurities

Page 17: Quality Control of Radiopharmaceuticals

• The presence of chemical impurities before radiolabeling may result in undesirable labeled molecules that may or may not interfere with the diagnostic test

• Undue chemical impurities may also cause a toxic effect

Chemical Purity

Page 18: Quality Control of Radiopharmaceuticals

• Purification of radiopharmaceuticals from Chemical impurities is often carried out by methods of chemical separation such as – Precipitation– Solvent extraction– Ion exchange– Distillation

Chemical Purity

Page 19: Quality Control of Radiopharmaceuticals

Radioassay

• The amount of radioactivity of a radiopharmaceutical before dispensing as well as that of each individual dosage before administration to patients must be determined

• These activity determinations are carried out by means of an isotope dose calibrator

Page 20: Quality Control of Radiopharmaceuticals

• According to the NRC regulations the following quality control tests must be performed at the frequencies indicated:

1. constancy (daily)2. accuracy (at installation, annually, and after

repairs)3. linearity (at installation, quarterly, and after

repairs)4. geometry (at installation and after repairs)

RadioassayDose Calibrator Quality Control

Page 21: Quality Control of Radiopharmaceuticals

1. constancy (daily)– The constancy test indicates the reproducibility of

measurements by a dose calibrator

2. accuracy (at installation, annually, and after repairs)• The accuracy of a dose calibrator is determined by

measuring the activities of at least two long-lived reference sources and comparing the measured activity with the stated activity

• The measured activity must agree with the stated activity within G10%.

RadioassayDose Calibrator Quality Control

Page 22: Quality Control of Radiopharmaceuticals

3. linearity (at installation, quarterly, and after repairs)• The linearity test indicates the dose calibrator’s ability to

measure the activity accurately over a wide range of values

4. geometry (at installation and after repairs)• Variations in sample volumes or geometric configurations of

the container

RadioassayDose Calibrator Quality Control

Page 23: Quality Control of Radiopharmaceuticals

Measurement of Radioactivity

• Radioactivity of a radiopharmaceutical is measured by placing the sample inside the dose calibrator with the appropriate isotope selector setting

• The reading is displayed in appropriate units (curie or becqurel) on the dial

Page 24: Quality Control of Radiopharmaceuticals

Biological Tests

• Carried out essentially to examine – The sterility– Apyrogenicity– Toxicity

of radiopharmaceuticals before human administration

Page 25: Quality Control of Radiopharmaceuticals

Biological TestsSterility

• Sterility indicates the absence of any viable bacteria or microorganisms in a radiopharmaceutical preparation

• Methods of Sterilization– Autoclaving– Membrane Filtration

Page 26: Quality Control of Radiopharmaceuticals

Apyrogenicity

• All radiopharmaceuticals for human administration are required to be pyrogen free

• Pyrogens are either polysaccharides or proteins produced by the metabolism of microorganisms

• They are 0.05 to 1 mm in size, soluble and heat stable

• Following administration pyrogens produce symptoms of – fever, chills, malaise, leukopenia, pain in joints,

flushing, sweating, headache, and dilation of the pupils

Page 27: Quality Control of Radiopharmaceuticals

• Pyrogenicity Testing• USP Rabbit Test• LAL (limulus amebocyte lysate)Test

– The principle of the test is based on the formation of an opaque gel by pyrogens upon incubating the sample with the LAL at 37C

– An assay mixture usually consists of 0.1 ml LAL and a test sample at pH 6 to 8

– The reaction takes place within 15 to 60 min after mixing and depends on the concentration of pyrogens

Page 28: Quality Control of Radiopharmaceuticals

Record Keeping

• Record keeping is mandatory for legal reasons as well as for tracing any faulty preparation

Page 29: Quality Control of Radiopharmaceuticals